16:30
#153 INHIBITORY EFFECT OF TADALAFIL, A PHOSPHODIESTERASE 5 INHIBITOR, ON BLADDER MECHANOSENSITIVE AFFERENT ACTIVITY IN THE RAT
Presenter: Tomonori Minagawa
Minagawa T1, Aizawa N1, Igawa Y2, Wyndaele J11. Department of Urology, Faculty of Medicine, University of Antwerp, 2. Department of Continence Medicine, University of Tokyo Graduate School of Medicine
16:35
#154 EFFECTS OF MIRABEGRON (YM178), A NOVEL BETA3-ADRENOCEPTOR AGONIST, ON THE PRIMARY BLADDER AFFERENT ACTIVITY OF THE RAT
Presenter: Naoki Aizawa
Aizawa N1, Homma Y2, Igawa Y11. Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, 2. Department of Urology, The University of Tokyo Graduate School of Medicine
16:40
#155 Role of extracellular Ca2+ influx through L-type Ca2+ channels (LVOCC) to bladder dysfunction and overactive detrusor smooth muscle in obese mice
Presenter: Luiz Osório Silveira Leiria
Leiria L O S1, Monica F1, Lintomen L1, Calixto M C1, Claudino M A1, Franco-Penteado C1, Antunes E11. State University of Campinas - UNICAMP
16:45
#156 GALANIN-MEDIATED REGULATION OF MICTURITION REFLEX IN URETHANE-ANESTHETIZED RATS
Presenter: Masashi Honda
Honda M1, Inoue S1, Takenaka A1, Chancellor M2, Yoshimura N31. Department of Urology, Faculty of Medicine, Tottori University, 2. Department of Urology, William Beaumont Hospital, 3. Department of Urology, University of Pittsburgh School of Medicine
16:50
#157 Noninvasive evaluation of brain muscarinic receptor occupancy of imidafenacin, darifenacin and oxybutynin in rats by positron emission tomography
Presenter: Shizuo Yamada
Yamada S1, Ito Y1, Yoshida A1, Tsukada H21. University of Shizuoka, 2. Hamamatsu Photonics
16:55
#158 Up-regulation of muscarinic receptor and purinergic receptor in the fructose-fed rat.
Presenter: Yoshihiko Ito
Ito Y1, Yoshida A1, Kojima N1, Yamada S11. University of Shizuoka
17:00
#159 Superiority of Desmopressin as oral lyophIlisate formulation compared to tablet, related to less interference by associated foodintake
Presenter: Johan Vande Walle
De Guchtenaere A1, Hoebeke P1, Van herzeele C1, Dehoorne J1, Raes A1, Van Laecke E1, Vande Walle J11. University Hospital Ghent
17:05
#160 A randomized study to assess the action of fesoterodine on urethral function in women with stress urinary incontinence using urethral pressure reflectometry
Presenter: Neils Klarskov
Klarskov N1, Darekar A2, Scholfield D2, Whelan L2, Lose G11. Dept of Obstetrics and Gynaecology, Herlev Hospital, Denmark, 2. Pfizer Ltd.
17:10
#161 Dose Formulation, Dose Selection, and Phase III Results for a Flexible Dose Gel for Transdermal Oxybutynin Delivery
Presenter: David Staskin
Staskin D1, Dave K21. Tufts University School of Medicine, 2. Antares Pharma
17:15
#162 Intravesical instillation of sodium hyaluronate after acute cystitis for prevention of recurrent UTIs
Presenter: Yakov Mirkin
Mirkin Y1, Bedretdinova D2, Smirnov G3, Eizenakh I41. URO-PRO clinic, 2. Central Institute of Urology, Moscow, 3. MKC Laboratories, Moscow, 4. NMT Bioresearch
17:20
#163 Pharmacokinetic characteristics of Desmopressin oral lyophilisate (melt) and tablet formulation in children
De Guchtenaere A1, Hoebeke P1, Van herzeele C1, Dehoorne J1, Raes A1, Van Laecke E1, De Bruyne P1, Vande Walle J11. University Hospital Ghent
17:25
#164 Comparative evaluation of the safety and efficacy of long-term use of Imidafenacin and Solifenacin in patients with overactive bladder: A prospective, open, randomized, parallel-group trial (the LIST study)
Presenter: Masayoshi Zaitsu
Zaitsu M1, Mikami K1, Ishida N2, Takeuchi T11. Department of Urology, Kanto Rosai Hospital, 2. Department of Pharmacy, Kanto Rosai Hospital